Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding, a leading cause of death from traumatic injuries. The treatment uses nanotechnology and biomaterials to accelerate the body's natural coagulation process to limit blood loss, save lives and minimize recovery time post-injury.
View Top Employees from Cayuga Biotech| Website | http://www.cayugabiotech.com |
| Revenue | $8 million |
| Employees | 2 (2 on RocketReach) |
| Address | 1228 Bath St, Santa Barbara, California 93101, US |
| Phone | (908) 938-1792 |
| Industry | Pharmaceuticals, Healthcare, Biotechnology, Drug Manufacturing & Research |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies |
Looking for a particular Cayuga Biotech employee's phone or email?
Cayuga Biotech Questions
The Cayuga Biotech annual revenue was $8 million in 2023.
Kyle Ploense is the CTO of Cayuga Biotech.
2 people are employed at Cayuga Biotech.
Cayuga Biotech is based in Santa Barbara, California.
The NAICS codes for Cayuga Biotech are [541, 5417, 54171, 54, 541713].
The SIC codes for Cayuga Biotech are [87, 873].
Top Cayuga Biotech Employees
-
ViewKyle Ploense
Chief Technology Officer at Cayuga Biotech
Santa Barbara, California, United States21 -
View
Kyle Ploense
Head Of Research And Development at Cayuga Biotech
Mount Vernon, New York, United States22
